Statin use and risk of hepatocellular carcinoma in a U.S. population
- McGlynn, Katherine A.
- Divine, George W.
- Sahasrabuddhe, Vikrant V.
- Engel, Lawrence S.
- VanSlooten, Ashley
- Wells, Karen
- Yood, Marianne Ulcickas
- Alford, Sharon Hensley
Publication date
January 2014
DOIAbstract
Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are medications widely prescribed to reduce cholesterol levels. Observational studies in high-risk populations, mostly in Asia, have suggested that statins are associated with a reduced risk of hepatocellular carcinoma (HCC). The current study sought to evaluate the association of statin use and HCC in a U.S.-based, low-risk, general population
Add to ORKG